Braidwell’s Fusion Pharmaceuticals FUSN Stock Holding History
Bought
Maintained
Sold
Other funds holding FUSN
Braidwell's FUSN Position: Q1 2023 in Review
Braidwell sold out of Fusion Pharmaceuticals (FUSN) in Q1 2023, closing a stake of 2,000,000 shares — an estimated $6.3M sold.
Braidwell first reported a position in FUSN in Q4 2022 and held it in 1 quarter. The position peaked at $6.3M in Q4 2022. 38 funds tracked by Wall St. Rank hold FUSN as of Q1 2023.
- Braidwell reported no remaining Fusion Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
- Braidwell sold 2,000,000 Fusion Pharmaceuticals shares in Q1 2023, an estimated $6.3M.
- Braidwell first reported a position in Fusion Pharmaceuticals in Q4 2022 and held it in 1 quarter.
- Braidwell's Fusion Pharmaceuticals position peaked at $6.3M in Q4 2022.
- 38 funds tracked by Wall St. Rank held Fusion Pharmaceuticals as of Q1 2023.
Based on Braidwell's 13F filing for Q1 2023, filed 15 May 2023.